Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001641172-25-006707
Filing Date
2025-04-29
Accepted
2025-04-29 17:29:51
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 478067
2 EXHIBIT 31.3 ex31-3.htm EX-31.3 6695
3 EXHIBIT 31.4 ex31-4.htm EX-31.4 6695
  Complete submission text file 0001641172-25-006707.txt   813310

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20241231.xsd EX-101.SCH 3786
5 XBRL DEFINITION FILE biaf-20241231_def.xml EX-101.DEF 27825
6 XBRL LABEL FILE biaf-20241231_lab.xml EX-101.LAB 38454
7 XBRL PRESENTATION FILE biaf-20241231_pre.xml EX-101.PRE 26440
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 10539
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41463 | Film No.: 25889662
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)